These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32978304)

  • 21. SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.
    Cooper DM; Afghani B; Byington CL; Cunningham CK; Golub S; Lu KD; Radom-Aizik S; Ross LF; Singh J; Smoyer WE; Lucas CT; Tunney J; Zaldivar F; Ulloa ER
    Pediatr Res; 2021 Nov; 90(5):966-970. PubMed ID: 33627824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reexamining the categorical exclusion of pediatric participants from controlled human infection trials.
    Murphy SC; Duenas DM; Richie TL; Shah SK
    Bioethics; 2020 Oct; 34(8):785-796. PubMed ID: 32715497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 human challenge studies: ethical issues.
    Jamrozik E; Selgelid MJ
    Lancet Infect Dis; 2020 Aug; 20(8):e198-e203. PubMed ID: 32479747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Human Challenge Trials: Rethinking the Recruitment of Healthy Young Adults First.
    Matsui K; Inoue Y; Yamamoto K
    Ethics Hum Res; 2021 May; 43(3):37-41. PubMed ID: 33821569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV prevention research and COVID-19: putting ethics guidance to the test.
    Rennie S; Chege W; Schrumpf LA; Luna F; Klitzman R; Moseki E; Brown B; Wakefield S; Sugarman J
    BMC Med Ethics; 2021 Jan; 22(1):6. PubMed ID: 33494754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Challenge Trials: Ethical and Legal Issues for COVID-19 Research.
    Freckelton I
    J Law Med; 2021 Mar; 28(2):311-322. PubMed ID: 33768743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine trials during a pandemic: potential approaches to ethical dilemmas.
    Alqahtani M; Mallah SI; Stevenson N; Doherty S
    Trials; 2021 Sep; 22(1):628. PubMed ID: 34526086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 Variants.
    Rohrig A; Eyal N
    J Infect Dis; 2022 Mar; 225(6):934-937. PubMed ID: 34624095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review.
    Al-Kuraishy HM; Al-Gareeb AI; Alkazmi L; El-Bouseary MM; Hamad RS; Abdelhamid M; Batiha GE
    J Immunol Res; 2023; 2023():5544819. PubMed ID: 37383608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O).
    Eckstein L; Rid A; Kamuya D; Shah SK
    Clin Infect Dis; 2021 Dec; 73(11):2126-2130. PubMed ID: 33758912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for COVID-19 among healthcare workers. A protocol for a systematic review and meta-analysis.
    Dzinamarira T; Mhango M; Dzobo M; Ngara B; Chitungo I; Makanda P; Atwine J; Nkambule SJ; Musuka G
    PLoS One; 2021; 16(5):e0250958. PubMed ID: 33945546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events.
    Eyal N
    Ethics Hum Res; 2020 Jul; 42(4):24-34. PubMed ID: 32441894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic.
    Piggin M; Smith E; Mankone P; Ndegwa L; Gbesemete D; Pristerà P; Bahrami-Hessari M; Johnson H; Catchpole AP; Openshaw PJM; Chiu C; Read RC; Ward H; Barker C
    Epidemics; 2022 Dec; 41():100626. PubMed ID: 36088739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.